Adequin Pharmaceutical Private Limited, a active private limited company, was established on 03 December 2020 in Bhubaneswar, Orissa, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U51909OR2020PTC034988. Registered under ROC Roc Cuttack. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹0.38 M.
Its leadership includes Nayana Parida (Director), Suresh Kumar Parida (Managing Director). Past directors included Rohit Parida. Its latest AGM occurred on 16 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No-296, Jagamara Khandagiri, Bhubaneswar, Orissa, 751030.
U51909OR2020PTC034988
034988
03 December 2020
₹1.50 M
₹0.38 M
Roc Cuttack
Unlisted
Active
Explore comprehensive insights into Adequin Pharmaceutical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nayana Parida | Director | 06 May 2022 | Current |
| Suresh Kumar Parida | Managing Director | 03 Dec 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 06 May 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Adequin Pharmaceutical Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 11.63% increase. The company also saw a slight improvement in profitability, with a 1.69% increase in profit. The company's net worth moved up by a moderate rise of 0.76%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Adequin Pharmaceutical had a public holding of 15.63%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Adequin Pharmaceutical has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Adequin Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Adequin Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Adequin Pharmaceutical Private Limited last Annual general meeting of members was held on 16 Sep 2024 as per latest MCA records. was recorded as a recent event.
Adequin Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Cuttack. was recorded as a recent event.
Nayana Parida was appointed as a Director was appointed as a Director on 06 May 2022 & has been associated with this company since 3 years 7 months . was recorded as a recent event.
Suresh Kumar Parida was appointed as a Managing Director was appointed as a Managing Director on 03 Dec 2020 & has been associated with this company since 5 years 14 days . was recorded as a recent event.
The activity Adequin Pharmaceutical Private Limited was registered on 03 Dec 2020 with Roc Cuttack & aged 5 years 14 days as per MCA records. was completed.
The CIN of Adequin Pharmaceutical Private Limited is U51909OR2020PTC034988.
Adequin Pharmaceutical Private Limited is headquartered at Plot No-296, Jagamara Khandagiri, Bhubaneswar, Orissa, 751030.
Adequin Pharmaceutical Private Limited was incorporated on 03 December 2020.
The current directors of Adequin Pharmaceutical Private Limited are
The primary industry of Adequin Pharmaceutical Private Limited is Trade.
Adequin Pharmaceutical Private Limited is unlisted.
The authorized capital of Adequin Pharmaceutical Private Limited is ₹1.50 M, and the paid-up capital is ₹0.38 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX